SLC13A3
Basic information
Region (hg38): 20:46557823-46684467
Links
Phenotypes
GenCC
Source:
- leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate (Limited), mode of inheritance: AR
- leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate (Limited), mode of inheritance: AR
- leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Neurologic | 30635937 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (173 variants)
- not_specified (59 variants)
- Leukoencephalopathy,_acute_reversible,_with_increased_urinary_alpha-ketoglutarate (9 variants)
- SLC13A3-related_disorder (3 variants)
- Prostate_cancer (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC13A3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000022829.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 43 | 55 | ||||
| missense | 108 | 116 | ||||
| nonsense | 3 | |||||
| start loss | 0 | |||||
| frameshift | 2 | |||||
| splice donor/acceptor (+/-2bp) | 3 | |||||
| Total | 2 | 3 | 117 | 46 | 11 |
Highest pathogenic variant AF is 0.0012375409
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SLC13A3 | protein_coding | protein_coding | ENST00000279027 | 13 | 118252 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 9.45e-7 | 0.984 | 125707 | 0 | 41 | 125748 | 0.000163 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.40 | 274 | 348 | 0.788 | 0.0000201 | 3892 |
| Missense in Polyphen | 114 | 162.41 | 0.70191 | 1817 | ||
| Synonymous | 0.569 | 145 | 154 | 0.942 | 0.00000999 | 1257 |
| Loss of Function | 2.21 | 14 | 26.2 | 0.534 | 0.00000142 | 279 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000448 | 0.000445 |
| Ashkenazi Jewish | 0.0000992 | 0.0000992 |
| East Asian | 0.000109 | 0.000109 |
| Finnish | 0.0000925 | 0.0000924 |
| European (Non-Finnish) | 0.000151 | 0.000149 |
| Middle Eastern | 0.000109 | 0.000109 |
| South Asian | 0.000164 | 0.000163 |
| Other | 0.000166 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: High-affinity sodium-dicarboxylate cotransporter that accepts a range of substrates with 4-5 carbon atoms. The stoichiometry is probably 3 Na(+) for 1 divalent succinate.;
- Pathway
- Bile salt and organic anion SLC transporters;Sodium-coupled sulphate, di- and tri-carboxylate transporters;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Transport of small molecules;Butanoate metabolism;TCA cycle
(Consensus)
Recessive Scores
- pRec
- 0.173
Intolerance Scores
- loftool
- 0.702
- rvis_EVS
- -0.82
- rvis_percentile_EVS
- 11.88
Haploinsufficiency Scores
- pHI
- 0.318
- hipred
- Y
- hipred_score
- 0.659
- ghis
- 0.439
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.502
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc13a3
- Phenotype
Gene ontology
- Biological process
- sodium ion transport;citrate transport;succinate transmembrane transport
- Cellular component
- plasma membrane;integral component of membrane;extracellular exosome
- Molecular function
- citrate transmembrane transporter activity;succinate transmembrane transporter activity;high-affinity sodium:dicarboxylate symporter activity;sodium:dicarboxylate symporter activity